Fear of Failure: Engaging Patients in Antimicrobial Stewardship after Fecal Transplantation for Recurrent Clostridium difficile Infection

Publisher： Cambridge University Press

E-ISSN： 1559-6834|38|1|127-129

ISSN： 0899-823x

Source： Infection Control & Hospital Epidemiology, Vol.38, Iss.1, 2016-10, pp. : 127-129

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Fecal microbiota transplantation: a new standard treatment option for Clostridium difficile infection

By Borody Thomas J   Brandt Lawrence J   Paramsothy Sudarshan   Agrawal Gaurav  

Expert Review of Anti-Infective Therapy, Vol. 11, Iss. 5, 2013-05 ,pp. : 447-449

Informa Healthcare

Access to resources Recommend Favorite

The long‐term effects of faecal microbiota transplantation for gastrointestinal symptoms and general health in patients with recurrent Clostridium difficile infection

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 3, 2018-02 ,pp. : 371-379

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Impact of Recurrent Clostridium difficile Infection on Patients’ Prevention Behaviors

By  

Infection Control & Hospital Epidemiology, Vol. 38, Iss. 11, 2017-09 ,pp. : 1351-1357

Cambridge University Press

Access to resources Recommend Favorite

Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 9, 2015-05 ,pp. : 835-843

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: faecal microbiota transplantation in combination with fidaxomicin to treat severe complicated recurrent Clostridium difficile infection

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 269-2813, Iss. 8, 2015-10 ,pp. : 1030-1030

John Wiley & Sons Inc

Access to resources Recommend Favorite